Julius, Michal
Lavsky, Hadas Shasha
Kalfon, Limor
Kfir, Nehama Cohen
Herskovits, Miriam
Wiesmann, Irith
Zaccai, Tzipora C. Falik https://orcid.org/0000-0003-0065-1922
Funding for this research was provided by:
Galilee Medical Center Research Fund
Bar-Ilan University
Article History
Received: 27 February 2024
Revised: 2 September 2024
Accepted: 3 September 2024
First Online: 30 October 2024
Declarations
:
: The study was reviewed and approved by the IRB of Galilee Medical Center, Nahariya. No informed consent from patients was requested. (IRB#_05-02-2007_GMC).
: Hadas Shasha Lavsky is a principal investigator of Alnylam Pharmaceuticals Illuminate A, B, and C studies and of Bayer Fiona and Fiona-OLE studies. The other authors have no conflict of interest to disclose.